Growth Metrics

electroCore (ECOR) Asset Writedowns and Impairment (2021 - 2026)

electroCore's quarterly Asset Writedowns and Impairment came in at $33000.0 in Q1 2026, up 137.5% year-on-year from $13894.7 in Q1 2025, and up 106.85% quarter-over-quarter from -$482000.0 in Q4 2025.

electroCore has reported Asset Writedowns and Impairment for 4 years, with the latest figure at $33000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Asset Writedowns and Impairment rose 137.5% year-over-year to $33000.0; the trailing twelve-month figure through Mar 2026 stood at $162000.0 (up 174.65% YoY), and the FY2025 full-year result was $41000.0, down 19.61% from the prior year.
  • Asset Writedowns and Impairment for Q1 2026 stood at $33000.0, up from -$482000.0 in the prior quarter.
  • The five-year high for Asset Writedowns and Impairment was $629000.0 in Q2 2025, with the low at -$482000.0 in Q4 2025.
  • Average Asset Writedowns and Impairment over 3 years is $2222.2, with a median of -$10000.0 recorded in 2023.
  • Peak annual rise in Asset Writedowns and Impairment reached 137.5% in 2026, while the deepest fall reached 137.5% in 2026.
  • Tracing ECOR's Asset Writedowns and Impairment over 3 years: stood at -$312000.0 in 2023, then slumped by 54.49% to -$482000.0 in 2025, then soared by 106.85% to $33000.0 in 2026.
  • The last three Asset Writedowns and Impairment figures came in at $33000.0 (Q1 2026), -$482000.0 (Q4 2025), and -$18000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 electroCore 92,394.96 -8.79 Mn 8.36 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 33,000.00
Mar 31, 2026 33,000.00
Dec 31, 2025 -482,000.00
Dec 31, 2025 -482,000.00
Sep 30, 2025 -18,000.00
Sep 30, 2025 -18,000.00
Jun 30, 2025 629,000.00
Jun 30, 2025 629,000.00
Mar 31, 2025 -88,000.00
Mar 31, 2025 -88,000.00
Dec 31, 2023 -312,000.00
Dec 31, 2023 -312,000.00
Sep 30, 2023 193,000.00
Sep 30, 2023 193,000.00
Jun 30, 2023 -10,000.00
Jun 30, 2023 -10,000.00
Mar 31, 2023 75,000.00
Mar 31, 2023 75,000.00
Dec 31, 2021 31,000.00
Dec 31, 2021 31,000.00